Profound Medical Corp. Files 6-K with Press Release

Ticker: PROF · Form: 6-K · Filed: Oct 17, 2024 · CIK: 1628808

Profound Medical Corp. 6-K Filing Summary
FieldDetail
CompanyProfound Medical Corp. (PROF)
Form Type6-K
Filed DateOct 17, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: filing, press-release, foreign-private-issuer

TL;DR

Profound Medical Corp. dropped a 6-K with a press release on Oct 17th. Check it out.

AI Summary

Profound Medical Corp. filed a Form 6-K on October 17, 2024, to report a press release dated the same day. The press release is incorporated by reference as Exhibit 99.1. The company is a foreign private issuer and is filing under the 1934 Act, indicating its principal executive office is located in Mississauga, Ontario.

Why It Matters

This filing indicates that Profound Medical Corp. has issued a press release, which may contain important updates or announcements relevant to investors.

Risk Assessment

Risk Level: low — This is a routine filing (6-K) that incorporates a press release, not a filing detailing significant financial events or changes.

Key Players & Entities

  • Profound Medical Corp. (company) — Registrant
  • October 17, 2024 (date) — Filing and Press Release Date
  • Mississauga, Ontario (location) — Principal Executive Office

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, have filed or are required to file with a stock exchange, or have distributed or are required to distribute to their security holders.

What is included as an exhibit in this filing?

Exhibit 99.1, a press release dated October 17, 2024, is included as an exhibit to this Form 6-K.

Which form does Profound Medical Corp. indicate it files annually?

Profound Medical Corp. indicates it files annually under Form 40-F.

Where are Profound Medical Corp.'s principal executive offices located?

Profound Medical Corp.'s principal executive offices are located at 2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5.

What is the Commission File Number for Profound Medical Corp.?

The Commission File Number for Profound Medical Corp. is 001-39032.

Filing Stats: 165 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-10-17 16:45:04

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PROFOUND MEDICAL CORP. (Registrant) Date: October 17, 2024 /s/ Rashed Dewan Rashed Dewan Chief Financial Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.